Americans pay nearly twice as much per capita for healthcare as citizens of other wealthy nations, yet we often rank lower in life expectancy. This isn’t because we consume more care; it’s because the structural mechanics of the U.S. system drive the price of every single unit of care significantly higher.
The first major driver is administrative bloat. The U.S. relies on a fragmented, multi-payer system. Hospitals and doctors must maintain massive billing departments just to negotiate with dozens of different insurance companies, each with its own rules.
The second driver is market consolidation. Hospital systems have merged aggressively, creating local monopolies. When a hospital is the only option in a region, it can dictate prices to insurers, who pass those costs directly to you in the form of higher premiums and deductibles.
The third driver is the pharmaceutical pricing structure, specifically the role of Pharmacy Benefit Managers (PBMs). PBMs are middlemen who negotiate drug prices, but they often take a cut of the list price as a rebate. This creates a perverse incentive to keep list prices high, because a higher list price means a larger rebate for the PBM and the insurer. You pay the high list price at the counter; they split the hidden rebate.
Most of the high cost of American healthcare doesn’t come from individual doctors or patients overusing care. It comes from the structure itself: a fragmented system with high administrative costs, high prices per service, and middlemen whose pay rises with list prices rather than with better care.
When reviewing your own insurance plan or medical bills, look for the gap between the “list price” and the negotiated rate. That difference is the PBM system at work. Understanding this mechanism is the first step to demanding a system that treats healthcare as essential infrastructure rather than a financial product.